OTCMKTS:OSIR - Osiris Therapeutics Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$9.60 +0.10 (+1.05 %)
(As of 06/19/2018 04:00 PM ET)
Previous Close$9.50
Today's Range$9.47 - $9.65
52-Week Range$4.20 - $9.98
Volume12,731 shs
Average Volume28,171 shs
Market Capitalization$320.74 million
P/E RatioN/A
Dividend YieldN/A
Beta0.56
Osiris Therapeutics logoOsiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix and Stravix for treating chronic wounds of diabetic foot ulcers, venous leg ulcers, pressure ulcers, arterial ulcers, and severe burns, as well as surgical and trauma wounds; BIO4 for bone repair and regeneration in spine, trauma, extremity, cranial, and foot and ankle surgeries; and Cartiform for treating articular cartilage lesions in the knee and other joints. The company also develops and markets Menvivo for the repair of meniscus; and TruSkin for treating chronic wounds. It markets and distributes its products directly to physicians, hospitals, and other healthcare providers, as well as through agents and distributors. Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.

Receive OSIR News and Ratings via Email

Sign-up to receive the latest news and ratings for OSIR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryBiotechnology
SectorMedical
SymbolOTCMKTS:OSIR
CUSIP68827R10
Phone443-545-1800

Debt

Debt-to-Equity RatioN/A
Current Ratio1.97
Quick Ratio1.68

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$118.51 million
Price / Sales2.80
Cash FlowN/A
Price / CashN/A
Book Value$1.20 per share
Price / Book8.00

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees350
Outstanding Shares34,530,000

Osiris Therapeutics (OTCMKTS:OSIR) Frequently Asked Questions

What is Osiris Therapeutics' stock symbol?

Osiris Therapeutics trades on the OTCMKTS under the ticker symbol "OSIR."

Who are some of Osiris Therapeutics' key competitors?

Who are Osiris Therapeutics' key executives?

Osiris Therapeutics' management team includes the folowing people:
  • Mr. Jason Keefer, Interim Pres & CEO (Age 46)
  • Dr. Alla N. Danilkovitch, Chief Scientific Officer (Age 54)
  • Mr. Joel David Rogers, Interim Chief Financial Officer (Age 56)
  • Mr. Edward Yip, Chief Legal Officer & Corp. Sec.
  • Mr. Laine Dyess, VP of Sales

Has Osiris Therapeutics been receiving favorable news coverage?

Media stories about OSIR stock have trended somewhat negative this week, according to Accern. The research group rates the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Osiris Therapeutics earned a news sentiment score of -0.20 on Accern's scale. They also assigned news articles about the biotechnology company an impact score of 45.91 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

How do I buy shares of Osiris Therapeutics?

Shares of OSIR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Osiris Therapeutics' stock price today?

One share of OSIR stock can currently be purchased for approximately $9.60.

How big of a company is Osiris Therapeutics?

Osiris Therapeutics has a market capitalization of $320.74 million and generates $118.51 million in revenue each year. Osiris Therapeutics employs 350 workers across the globe.

How can I contact Osiris Therapeutics?

Osiris Therapeutics' mailing address is 7015 ALBERT EINSTEIN DRIVE, COLUMBIA MD, 21046. The biotechnology company can be reached via phone at 443-545-1800 or via email at [email protected]


MarketBeat Community Rating for Osiris Therapeutics (OSIR)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  87 (Vote Outperform)
Underperform Votes:  144 (Vote Underperform)
Total Votes:  231
MarketBeat's community ratings are surveys of what our community members think about Osiris Therapeutics and other stocks. Vote "Outperform" if you believe OSIR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OSIR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.